deltatrials
Completed PHASE1 INTERVENTIONAL 3-arm NCT02299661

Pilot PK/PD Study of DS-1093a in Patients With Chronic Kidney Disease

An Open-Label, Randomised, Parallel Group Pilot Study to Assess the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Single Doses of DS-1093a in Patients With Chronic Kidney Disease

Sponsor: Daiichi Sankyo

Conditions Chronic Renal Disease Renal Anemia
Interventions DS-1093a
Updated 9 times since 2017 Last updated: Dec 20, 2018 Started: Nov 30, 2014 Primary completion: May 31, 2015 Completion: May 31, 2015
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02299661, this PHASE1 trial focuses on Chronic Renal Disease and Renal Anemia and remains completed. Sponsored by Daiichi Sankyo, it has been updated 9 times since 2014, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~Sep 2017 · 8 months · monthly snapshotCompleted~Sep 2017 – ~Jun 2018 · 9 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2019 · 7 months · monthly snapshotCompleted~Jan 2019 – ~Jan 2021 · 24 months · monthly snapshotCompleted~Jan 2021 – ~Mar 2024 · 38 months · monthly snapshotCompleted~Mar 2024 – ~Jul 2024 · 4 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotCompleted~Sep 2025 – present · 10 months · monthly snapshotCompleted

Change History

9 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE1

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE1

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1

  4. Mar 2024 — Jul 2024 [monthly]

    Completed PHASE1

  5. Jan 2021 — Mar 2024 [monthly]

    Completed PHASE1

▶ Show 4 earlier versions

  1. Jan 2019 — Jan 2021 [monthly]

    Completed PHASE1

  2. Jun 2018 — Jan 2019 [monthly]

    Completed PHASE1

  3. Sep 2017 — Jun 2018 [monthly]

    Completed PHASE1

  4. Jan 2017 — Sep 2017 [monthly]

    Completed PHASE1

    First recorded

Nov 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Daiichi Sankyo
  • PRA Health Sciences
Data source: Daiichi Sankyo

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations